Companies

Treatment of leukemia would not be possible without the help of companies developing novel agents.

The ELN Foundation was supported with unrestricted grants by the companies Epicept, Glaxo SmithKline and Pfizer.

 

Print this Document   Sitemap   Contact  


 
top